Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)

Site 90027-009, Witbank

Site 90027-010, Johannesburg

Site 90045-006, Hvidovre

Site 90027-004, Cape Town

Site 90027-005, Cape Town

Site 90045-003, Herning

Site 90027-001, Cape Town

Site 90027-008, Cape Town

Site 90034-006, L'Hospitalet de Llobregat

Site 90027-003, Bloemfontein

Site 90034-004, Córdoba

Site 90034-003, A Coruña

Site 90001-047, Boca Raton

Site 90034-001, Reus

Site 90001-002, Cincinnati

Site 90034-002, Zaragoza

Site 90001-056, Saint Paul

Site 90001-012, Butte

Site 90001-112, Las Vegas

Site 90001-001, Newport Beach

Site 90001-005, Mission Viejo

Site 90001-015, Stanford

Site 90001-004, Boston

Site 90001-014, Summit

Site 90011-005, Chicoutimi

Site 90011-001, Montreal

Site 90011-002, Québec

Site 90420-001, Prague

Site 90420-006, Prague

Site 90420-005, Trutnov

Site 90045-001, Aalborg

Site 90045-004, Esbjerg

Site 90045-002, Roskilde

Site 90045-005, Viborg

Site 90031-001, Amersfoort

Site 90031-003, Amsterdam

Site 90031-009, Hoorn

Site 90031-006, Tilburg

Site 90031-005, Utrecht

Site 90027-007, Pretoria

Site 90027-006, Pretoria

Site 90034-005, Barcelona

Site 90046-002, Gothenburg

Site 90046-001, Stockholm

Site 90046-003, Stockholm